2003
DOI: 10.1097/01.tp.0000058517.07194.90
|View full text |Cite
|
Sign up to set email alerts
|

Hyperacute lung rejection in the pig-to-human model. III. platelet receptor inhibitors synergistically modulate complement activation and lung injury

Abstract: Platelet protein receptor adhesive interactions play an important role in amplification of complement activation during hyperacute lung rejection. Inhibiting recruitment of platelets at the site of initial immunologic injury to endothelial cells may protect porcine organs against thrombosis and inflammation during the initial exposure to human blood.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

5
42
0

Year Published

2005
2005
2023
2023

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 30 publications
(47 citation statements)
references
References 23 publications
5
42
0
Order By: Relevance
“…Immediate or early thrombocytopenia is not seen after Tx of pig hearts or kidneys into baboons under similar experimental conditions (19)(20)(21)(22), though it is seen early after pig lung Tx (35) …”
Section: (A) Macroscopic Appearance Of the Pig Liver In B18908 At Necmentioning
confidence: 99%
“…Immediate or early thrombocytopenia is not seen after Tx of pig hearts or kidneys into baboons under similar experimental conditions (19)(20)(21)(22), though it is seen early after pig lung Tx (35) …”
Section: (A) Macroscopic Appearance Of the Pig Liver In B18908 At Necmentioning
confidence: 99%
“…According to Fiane et al, a more effective inhibition of inflammatory pathways, especially the complement system, seems necessary to achieve prolonged survival of xenografts (15). Currently it is hypothesized that platelet aggregation is an early important step in hyperacute rejection, required for amplification of the complement cascade (17).…”
Section: Discussionmentioning
confidence: 98%
“…In a pig-to-human lung perfusion model, blockade of GPI/von Willebrand factor alone or in combination with the GPIIb/ IIIa axes of platelet activation was able to blunt complement activation and prolonged xenograft survival (33). Pfeiffer et al showed that, among other factors, the GPIIb/IIIa receptordependent adhesive interactions between platelets and the vessel wall or other platelets are required for efficient activation of the complement cascade (17). Although combined blockade of GPIb and GPIIb/IIIa demonstrated synergy with respect to limited inhibition of complement activation, formation of activated complement factor C3b was not prevented.…”
mentioning
confidence: 97%
See 1 more Smart Citation
“…It was reported that approximately 82% of the platelets disappeared from the perfusate during the first minute of perfusion of swine lung with human blood [2]. Therapy with anti-GPIb monoclonal antibody inhibited platelet deposition on the xenograft [15] and inhibitors for the interaction between GPIb or GPIIIa and vWF attenuated the increase of pulmonary vascular resistance and release of thrombin and histamine [15]. However, an anti-platelet monoclonal antibody can lead to sequestration of platelets to the reticuloendothelial system [16] and thus, non-selective inhibition of the recipient's platelet function can cause possible hemorrhagic complications or systemic shock.…”
Section: Discussionmentioning
confidence: 99%